Newswise — June 30, 2022 – "On a scale of 1 to 5, how satisfied are you with the appearance of your breasts?" For nearly 40% of women after breast reconstruction, perceptions are substantially better or worse compared to ratings by third-party observers, concludes a study in the July issue of Plastic and Reconstructive Surgery®, the official medical journal of the American Society of Plastic Surgeons (ASPS).
These "incongruous" ratings of aesthetic results after breast reconstruction are linked to differences in key areas of quality of life (QoL), according to the report by ASPS Member Surgeon Graham S. Schwarz, MD, of the Cleveland Clinic and colleagues. Dr. Schwarz comments, "Our findings suggest that women's perceptions of their aesthetic outcomes may be affected by satisfaction in other areas, such as psychological, physical, and sexual well-being."
New insights into varied patient satisfaction after breast reconstruction
Patient-reported outcomes are the main measure of the success of breast reconstruction after mastectomy for breast cancer. However, women's perceptions of the outcomes of breast reconstruction vary widely, and may be influenced by psychological, physical, or other factors. Third-party observations by independent raters provide a way of "separating the aesthetic assessment of the breast from the [patient's] personal, lived experience," according to the authors.
In the new study, 147 women rated their aesthetic outcomes after breast reconstruction using a validated questionnaire (BREAST-Q), which also assessed QoL factors in several domains. The patients' ratings were compared to independent ratings by a panel of third-party observers (including plastic surgeons and final-year medical students), based on post-reconstruction photographs using a standard assessment (the Validated Breast Aesthetic Scale, or VBRAS).
For 63% of women, satisfaction with their aesthetic results aligned with the independent ratings. However, 19% of women rated their aesthetic outcomes lower than the third-party observers – for this group, median score for satisfaction with breasts was 3 on a 5-point scale. The remaining 18% of women rated their results higher than the independent raters: median score 4 points out of 5.
When the researchers looked at other BREAST-Q responses, the disparities in aesthetic ratings were related to scores for several areas of QoL. Women with "incongruously high" ratings of breast appearance reported higher levels of psychosocial, physical, and sexual well-being. In contrast, women with "incongruously low" ratings had lower scores in the same three QoL domains.
The mismatches were related not only to the appearance of the breast, but also to satisfaction with the abdomen and overall outcome. In contrast, the incongruous ratings were unrelated to patient factors such as age or body mass index; or to clinical factors such as the type and timing of breast reconstruction or the use of adjuvant treatments (chemotherapy and/or radiation) in addition to mastectomy.
As more women undergo breast reconstruction after mastectomy for breast cancer, there is a growing focus on patient satisfaction and outcomes. In 2020, ASPS Member Surgeons performed more than 138,000 breast reconstruction procedures, according to ASPS statistics.
The study provides new insights into the variation in patient-reported outcomes after breast reconstruction. As in previous studies, "an aesthetically pleasing breast does not guarantee patient satisfaction," the researchers write. The associations with QoL factors "demonstrate the importance of psychometric characteristics on postoperative satisfaction."
"Our results impact shared decision-making between patient and physician in the preoperative planning stages," Dr. Schwarz and coauthors conclude. "Evaluation of a patient with low baseline psychosocial, sexual, or physical functioning...may warrant further discussion about expectations of postoperative outcomes."
"Our study is unique in our attempts to use two validated instruments – the BREAST-Q AND VBRAS – to explore this gap in perception between breast reconstruction patients and third parties," Dr. Schwarz comments. "We also hope our approach opens up a new avenue to study disparity in perception across many plastic surgical procedures."
DOI: 10.1097/PRS.0000000000009254
###
Plastic and Reconstructive Surgery® is published in the Lippincott portfolio by Wolters Kluwer.
About Plastic and Reconstructive Surgery
For over 75 years, Plastic and Reconstructive Surgery® (http://www.prsjournal.com/) has been the one consistently excellent reference for every specialist who uses plastic surgery techniques or works in conjunction with a plastic surgeon. The official journal of the American Society of Plastic Surgeons, Plastic and Reconstructive Surgery® brings subscribers up-to-the-minute reports on the latest techniques and follow-up for all areas of plastic and reconstructive surgery, including breast reconstruction, experimental studies, maxillofacial reconstruction, hand and microsurgery, burn repair and cosmetic surgery, as well as news on medico-legal issues.
About ASPS
The American Society of Plastic Surgeons is the largest organization of board-certified plastic surgeons in the world. Representing more than 7,000 physician members, the society is recognized as a leading authority and information source on cosmetic and reconstructive plastic surgery. ASPS comprises more than 94 percent of all board-certified plastic surgeons in the United States. Founded in 1931, the society represents physicians certified by The American Board of Plastic Surgery or The Royal College of Physicians and Surgeons of Canada.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2021 annual revenues of €4.8 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,800 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students in effective decision-making and outcomes across healthcare. We support clinical effectiveness, learning and research, clinical surveillance and compliance, as well as data solutions. For more information about our solutions, visit https://www.wolterskluwer.com/en/health and follow us on LinkedIn and Twitter @WKHealth.
For more information, visit www.wolterskluwer.com, follow us on Twitter, Facebook, LinkedIn, and YouTube.
RSS